1Lusuardi M, Cape I A, Carli S, et al. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration, 1992, 59( Suppl 1):28-32.
2Gillissen A, Nowak D. Characterization of N - acetylcysteine and ambroxol in antioxedant therapy. Respir Mod, 1998,92(4) :609 - 623.
3Houtmeyers E. Effects of drugs on mucus clearance. Eur Respir J, 1999,14(2) :452 - 467.
4Zasshi NY. Effects of ambroxol HCl on the guinea pig tracheal mucous secretion and the rat pulmonary suffactant secretion. Uchidn-M, 1992, 100(4) :293 - 300.
5Derelle J, Bertolo HE, Marchal F, et al. Respiratory evolution of patient with mucoviscidosis trentted with mucolytic agents plus domase alfa. Arct - Pediatr, 1998,5(4) :371 - 377.
